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Evidence Based Medicine
Surgical interventions for malignant middle cerebral infarction — saving
lives and functionality or increasing disabled survivors?
Maria Khan, Ayeesha Kamran Kamal

Stroke Service and Vascular Fellowship Program, Aga Khan University Hospital, Karachi.

Why is this study important?

Malignant Middle Cerebral Artery infarctions are
associated with 80% mortality. The patients affected are
young and when cerebral oedema peaks at day three to four
after stroke, herniation and death occurs. Since stroke affects
Asians at a younger age, studies done on this disease are
pertinent, especially if the interventions are technically
possible in hospitals within Pakistan.

Before these studies were carried out, non randomized
trials had shown that decompressive surgeries reduced
mortality in these patients. But there was no mortality data
from randomized studies and the long term outcome of the
survivors was also not known.
The three trials were conducted independently in three
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different European countries, DESTINY in Germany,
DECIMAL in France and HAMLET in Netherlands. Before
the completion of the trials it was decided that the results will
be pooled since the trials had similar design and shared the
same primary outcome measure. We present here the pooled
results.

Who were the participants?

All three trials included patients who were 18-60 years
of age and had presented with clinical deficits suggestive of
large Middle cerebral artery infarction, their NIHSS score was
>15 and they had radiological evidence of a large MCA
infarction. The time window for inclusion in the pooled
analysis was 45 hours, although for individual trials the
window was 36 hours for DECIMAL and DESTINY and 96
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hours for HAMLET. These patient characteristics are very
similar to what we see here in our clinical practice, most of our
patients are within this age range, and do manage to get to a
tertiary care hospital within this time window.3

The projected sample sizes were larger but due to the
opportunity of pooled analysis, all three trials were terminated
early. A total of 93 patients were included in the pooled
analysis. DECIMAL contributed 38 patients to the pooled
analysis, DESTINY contributed 32 patients and HAMLET 23
patients. Hamlet went on to recruit a further 41 patients after
the pooled analysis had been done.

What was the intervention?

In all three trials the patients were randomized to either
decompressive surgery or medical management and in all
three trials the randomization was done centrally by a
computer. Decompressive surgery consisted of a duraplasty
and the creation of a large bone flap. In the conservative
group, patients received best medical treatment on the basis of
published guidelines for the management of acute ischaemic
stroke and space-occupying brain oedema.

What was their outcome?

In the pooled analysis the primary outcome measure
was the score on the modified Rankin scale(mRS) at one year
dichotomized between favourable (0-4) and unfavourable (5
or death). Secondary analyses included a dichotomization of
the mRS, in which favourable outcome was defined as a score
of 0-3 and unfavourable outcome as a score of 4 to death, and
case fatality at 1 year.
For the primary outcome, fewer patients had an
unfavourable outcome at 12 months (mRS 0-4), in the surgical
arm, as compared to the conservative arm (p<0.0001).
Significantly fewer patients had an mRS score greater than 3 at 12
months after surgical treatment than after conservative treatment
(p<0.014). The survival rate at 12 months was higher after
surgical treatment than after conservative treatment (p<0.0001).

The results of HAMLET show that surgical
decompression within 4 days of symptom onset does not
reduce poor outcome in patients with space-occupying
hemispheric infarction, despite a substantial reduction in case
fatality in these patients. Surgical decompression does,
however, reduce the probability of a poor outcome in patients
who were randomized within 48 hours of symptom onset.
Therefore the decompressive surgery is beneficial if
performed early on.

What were their conclusions?

The authors conclude that after decompressive surgery
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the probability of survival increases from 28% to nearly 80%
and the probability of survival with an mRS of > 3 doubles.
mRS 3 means an individual with moderate disability who can
still mobilize without assistance. However, the probability of
surviving in a condition requiring assistance from others for
walking and for bodily needs (mRS of 4) increases more than
ten times. The choice of performing decompressive surgery in
an individual patient with space-occupying hemispheric
infarction will therefore depend on the willingness to accept
survival with moderate disability. Information about quality of
life of survivors is essential for guiding such decisions.

So is decompressive hemicraniectomy a feasible
option in Pakistan?

The three studies have clearly established that
decompressive surgery has morality benefit in large hemispheric
infarctions if performed within 48 hours. They have also shown
that the outcome of patients is also better with surgery. However,
the risk of surviving with moderate disability increases.
These results raise several points to ponder before we
adopt this as a "routine strategy in Pakistan". There are no
chronic rehabilitation centers for stroke- so dealing with a
larger proportion of disabled patients may be a challenge.
Additionally, what the study does not address is whether
patients of older age group i.e. >60 years will also benefit from
decompressive surgeries, so one must be restricted in offering
this operation to all. Decompressive Hemicraniectomy has
been carried out for brain trauma and although it may be
technically feasible, its benefits are realized only in centers
with aggressive and protocolized supportive medical care- the
latter may be difficult to achieve.
On a more positive note, in young patients, done early,
the chances of independence double, when the surgery is
supported by an equally strong medical support team.
Provided these conditions are met- there is now hope for a
devastating condition.
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